FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to organ transplantation and clinical laboratory diagnostics. Determine the concentration of plasma protein A (PAPP-A) in the recipient's peripheral blood plasma, and when the level of PAPP-A is above 7 mIU/L, the presence of acute transplant rejection is diagnosed.
EFFECT: method allows reducing the time of diagnostics while simultaneously achieving reliable diagnosis of acute graft rejection, as well as to increase the survival rate of recipients and improve the results of heart transplantation due to timely determination of indications for unscheduled endomyocardial biopsy.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREOPERATIVE PREDICTION OF ACUTE CELLULAR REJECTION OF A TRANSPLANTED HEART | 2022 |
|
RU2798948C1 |
| METHOD FOR NON-INVASIVE DIAGNOSIS OF MYOCARDIAL FIBROSIS OF TRANSPLANTED HEART AT A LONG POST-TRANSPLANTATION PERIOD IN RECIPIENTS SUFFERING ACUTE REJECTION | 2019 |
|
RU2709193C1 |
| METHOD FOR NONINVASIVE DIAGNOSIS OF MYOCARDIAL FIBROSIS OF CARDIAC ALLOGRAFT | 2021 |
|
RU2772054C1 |
| METHOD FOR DIAGNOSING ACUTE REJECTION OF TRANSPLANT IN TRANSPLANTED HEART RECIPIENT | 2020 |
|
RU2758973C1 |
| METHOD FOR NON-INVASIVE DIAGNOSIS OF MYOCARDIAL FIBROSIS IN TRANSPLANTED HEART | 2021 |
|
RU2758993C1 |
| METHOD FOR NON-INVASIVE DIAGNOSIS OF MYOCARDIAL FIBROSIS IN DONOR HEART RECIPIENTS | 2021 |
|
RU2761470C1 |
| METHOD FOR NON-INVASIVE DIAGNOSIS OF MYOCARDIAL FIBROSIS IN CARDIAC TRANSPLANT RECIPIENTS | 2021 |
|
RU2760093C1 |
| METHOD FOR DIAGNOSING ACUTE TRANSPLANT REJECTION IN TRANSPLANTED HEART RECIPIENTS | 2020 |
|
RU2758994C1 |
| METHOD OF SCREENING DIAGNOSTICS OF ACUTE CELLULAR REJECTION OF TRANSPLANTED HEART | 2016 |
|
RU2614726C1 |
| SCREENING DIAGNOSIS METHOD OF ACUTE CELLULAR REJECTION OF TRANSPLANTED HEART | 2015 |
|
RU2618404C1 |
